Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa-Lyonnet

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Gynecologie, Obstetrique & Fertilite|December 4, 2003
[Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations.Gynécol Obstét Fertil 2003;31:370-377]D Stoppa-Lyonnet
Contraception, Fertilite, Sexualite (1992)|September 25, 1999
[Genetic predisposition to breast cancer: a review in April 1998]D Stoppa-Lyonnet
Presse Medicale (Paris, France : 1983)|April 16, 1998
[Genetic predispositions to breast cancer]D Stoppa-Lyonnet
Annales De Chirurgie Plastique Et Esthetique|November 13, 2025
[Genetic predisposition to breast cancer]D Stoppa-Lyonnet, C Colas
Bulletin Du Cancer|January 1, 1992
[Ataxia telangiectasia: what impact in clinical oncology?]D Stoppa-Lyonnet, A Aurias
Bulletin Du Cancer|November 30, 1999
[The goals and limits of the debate]N Janin, D Stoppa-Lyonnet
The New England Journal of Medicine|May 2, 1996
Breast cancer and BRCA1 mutationsG Ithier, M Girard, D Stoppa-Lyonnet
Bulletin Du Cancer|November 30, 1999
[Under what conditions should we propose a prophylactic mastectomy for a woman at risk?]M Gauthier-Villars, C Blandy, D Stoppa-Lyonnet
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2004
External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 yearsC R Mueller, U Kristoffersson, D Stoppa-Lyonnet
Bulletin Du Cancer|September 30, 1998
[Psychosocial impact of the first oncogenetic consultation in a familial context of cancers of the breast and the ovary]C Blandy, S Schwab, D Stoppa-Lyonnet, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Gynecologie, Obstetrique & Fertilite|December 4, 2003
[Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations.Gynécol Obstét Fertil 2003;31:370-377]D Stoppa-Lyonnet
Contraception, Fertilite, Sexualite (1992)|September 25, 1999
[Genetic predisposition to breast cancer: a review in April 1998]D Stoppa-Lyonnet
Presse Medicale (Paris, France : 1983)|April 16, 1998
[Genetic predispositions to breast cancer]D Stoppa-Lyonnet
Annales De Chirurgie Plastique Et Esthetique|November 13, 2025
[Genetic predisposition to breast cancer]D Stoppa-Lyonnet, C Colas
Bulletin Du Cancer|January 1, 1992
[Ataxia telangiectasia: what impact in clinical oncology?]D Stoppa-Lyonnet, A Aurias
Bulletin Du Cancer|November 30, 1999
[The goals and limits of the debate]N Janin, D Stoppa-Lyonnet
The New England Journal of Medicine|May 2, 1996
Breast cancer and BRCA1 mutationsG Ithier, M Girard, D Stoppa-Lyonnet
Bulletin Du Cancer|November 30, 1999
[Under what conditions should we propose a prophylactic mastectomy for a woman at risk?]M Gauthier-Villars, C Blandy, D Stoppa-Lyonnet
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2004
External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 yearsC R Mueller, U Kristoffersson, D Stoppa-Lyonnet
Bulletin Du Cancer|September 30, 1998
[Psychosocial impact of the first oncogenetic consultation in a familial context of cancers of the breast and the ovary]C Blandy, S Schwab, D Stoppa-Lyonnet, et al.
Pageof 13